Superworth

Definium Therapeutics EPS DFTX

Diluted earnings per share by quarter and over the last twelve months, from 2021.

Last 12 months, to Jun 30, 2026
−$3.43
Latest quarter, Q2 FY26
−$1.44
Fiscal year 2025
−$2.13

Definium Therapeutics' earnings per share was −$3.43 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$1.44.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$2.13n/a
FY2024−$2.08n/a
FY2023−$2.45n/a
FY2022−$1.95n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$1.44n/a−$3.43
Q1 FY26−$0.71n/a−$2.49
Q4 FY25−$0.50n/a−$2.13
Q3 FY25−$0.78n/a−$2.04
Q2 FY25−$0.50n/a−$1.53
Q1 FY25−$0.35n/a−$1.29
Q4 FY24−$0.41n/a−$2.08
Q3 FY24−$0.27n/a−$2.26
Q2 FY24−$0.26n/a−$2.44
Q1 FY24−$1.14n/a−$2.94
Q4 FY23−$0.59n/a−$2.45
Q3 FY23−$0.45n/a−$1.99

Against its peers

Companies in Chemicals nearest Definium Therapeutics' size, closest first, today.

CompanyEPS, 12 monthsGrowth
DFTXDefinium Therapeutics−$3.43
CSWCSW Industrials$7.29−13% a year
BCPCBalchem$5.09+16% a year
HXLHexcel$1.99+84% a year
CBTCabot$3.54−54% a year
AVNTAvient$1.85+43% a year
EMNEastman Chemical$3.84−46% a year
WDFCWD 40$6.58+4% a year
ESIElement Solutions$0.74−26% a year
FULFuller H B$3.59+72% a year
IOSPInnospec$4.90+545% a year
Peer median$3.71

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Definium Therapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.